Elisabeth Ida Specht Stovgaard

Elisabeth Ida Specht Stovgaard

Clinical Associate Professor

Member of:

  • Pathology


Publication year:
All
1 - 4 out of 4Page size: 10
  1. 2022
  2. Published

    Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial

    Shenasa, E., Stovgaard, Elisabeth Ida Specht, Jensen, M. B., Asleh, K., Riaz, N., Gao, D., Leung, S., Ejlertsen, Bent Laursen, Lænkholm, Anne-Vibeke & Nielsen, T. O., 2022, In: Cancers. 14, 15, 14 p., 3808.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Prognostic and Clinicopathologic Associations of LAG-3 Expression in Triple-negative Breast Cancer

    Stovgaard, Elisabeth Ida Specht, Kümler, Iben, List-Jensen, K., Roslind, A., Christensen, I. J., Høgdall, Estrid Vilma Solyom, Nielsen, D. & Balslev, E., 2022, In: Applied Immunohistochemistry and Molecular Morphology. 30, 1, p. 62-71

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. 2021
  5. Published

    The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    El Bairi, K., Haynes, H. R., Blackley, E., Fineberg, S., Shear, J., Turner, S., de Freitas, J. R., Sur, D., Amendola, L. C., Gharib, M., Kallala, A., Arun, I., Azmoudeh-Ardalan, F., Fujimoto, L., Sua, L. F., Liu, S. W., Lien, H. C., Kirtani, P., Balancin, M., El Attar, H. & 31 others, Guleria, P., Yang, W., Shash, E., Chen, I. C., Bautista, V., Do Prado Moura, J. F., Rapoport, B. L., Castaneda, C., Spengler, E., Acosta-Haab, G., Frahm, I., Sanchez, J., Castillo, M., Bouchmaa, N., Md Zin, R. R., Shui, R., Onyuma, T., Yang, W., Husain, Z., Willard-Gallo, K., Coosemans, A., Perez, E. A., Provenzano, E., Choi, H. J., Lænkholm, Anne-Vibeke, Stovgaard, Elisabeth Ida Specht, Nielsen, T., Balslev, E., Sharma, A., Garbyal, Rajendra Singh & The International Immuno-Oncology Biomarker Working Group, T. I. I. B. W. G., 2021, In: npj Breast Cancer. 7, 1, 17 p., 150.

    Research output: Contribution to journal › Review › Research › peer-review

  6. 2020
  7. Published

    Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Kos, Z., Roblin, E., Kim, R. S., Michiels, S., Gallas, B. D., Chen, W., van de Vijver, K. K., Goel, S., Adams, S., Demaria, S., Viale, G., Nielsen, T. O., Badve, S. S., Symmans, W. F., Sotiriou, C., Rimm, D. L., Hewitt, S., Denkert, C., Loibl, S., Luen, S. J. & 31 others, Bartlett, J. M. S., Savas, P., Pruneri, G., Dillon, D. A., Cheang, M. C. U., Tutt, A., Hall, J. A., Kok, M., Horlings, H. M., Madabhushi, A., van der Laak, J., Ciompi, F., Lænkholm, Anne-Vibeke, Bellolio, E., Gruosso, T., Fox, S. B., Araya, J. C., Floris, G., Hudeček, J., Voorwerk, L., Beck, A. H., Kerner, J., Larsimont, D., Declercq, S., Van den Eynden, G., Pusztai, L., Ehinger, A., Singh, R., Balslev, E., Stovgaard, Elisabeth Ida Specht & International Immuno-Oncology Biomarker Working Group, I. I. B. W. G., 2020, In: npj Breast Cancer. 6, p. 17

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 250853973